Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent

Details for Australian Patent Application No. 2011203970 (hide)

Owner Vivus, Inc.

Inventors Wilson, Leland; Tam, Peter; Najarian, Thomas; Bowden, Charles H.

Agent Cullens

Pub. Number AU-A-2011203970

PCT Pub. Number WO2011/085256

Priority 61/293,129 07.01.10 US

Filing date 7 January 2011

Wipo publication date 14 July 2011

International Classifications

A61K 9/16 Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/165 - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/195

A61K 31/425 - Thiazoles

A61K 31/54 - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

A61P 11/00 Drugs for disorders of the respiratory system

A61P 11/16 Drugs for disorders of the respiratory system

Event Publications

12 July 2012 PCT application entered the National Phase

  PCT publication WO2011/085256 Priority application(s): WO2011/085256

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203977-Method to use gene expression to determine likelihood of clinical outcome of renal cancer

2011203968-Eyewear earstem devices and methods